Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis

被引:93
作者
Chang, Yu-Ting [1 ]
Chang, Ming-Chu [1 ]
Su, Ta-Chen [1 ,2 ]
Liang, Po-Chin [3 ]
Su, Yi-Ning [4 ]
Kuo, Chun-Hung [1 ]
Wei, Shu-Chen [1 ]
Wong, Jau-Min [1 ]
机构
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei 10764, Taiwan
[2] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan
[3] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Radiol, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Med Genet, Taipei 10764, Taiwan
关键词
D O I
10.1373/clinchem.2007.093492
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: The mechanism by which hypertriglyceridemia (HTG) leads to pancreatitis is not clear. We sought to determine whether the genes involved in pancreatic ductal or acinar cell injury, including the cationic trypsinogen gene [protease, serine, 1 (trypsin 1) (PRSS1)], the pancreatic secretory trypsin inhibitor gene [serine peptidase inhibitor, Kazal type I (SPINK1)], the cystic fibrosis transmembrane conductance regulator gene [cystic fibrosis transmembrane conductance regulator (ATP-binding cassette subfamily C, member 7) (CFTR)], and inflammation genes such as tumor necrosis factor [tumor necrosis factor, TNF superfamily, member 2 (TNF)] are associated with hyperlipidemic pancreatitis (HLP) in patients with HTG. METHODS: We performed genetic analysis of 126 HTG patients in Taiwan (46 with HLP and 80 without HLP). The entire coding and intronic regions of the PRSS1, SPINK1, and CFTR genes were identified by heteroduplex analysis techniques and were confirmed by sequencing analysis. The presence of 125G/C, 1001 + IIC>T, 1540A>G (Met470Val), 2694T>G, and 4521G>A in CFTR, the presence of 272C>T in SPINK1, and TNF promoter polymorphisms (nucleotide positions 1031, 863, 857, 308, and 308) were measured by direct sequencing. RESULTs: Of the 126 HTG patients, 13 (10.3%) carried a CFTR mutation. No PRSS1 or SPINK1 mutations were detected in our patients or in HTG controls. The CFTR gene mutation rates in HTG with and without HLP were 26.1% (12 of 46) and 1.3% (1 of 80), respectively (P <0.0001). The CFTR gene mutations were all Ile556Val. A multivariate analysis of HTG patients indicated that triglycerides, CFTR 470Val, and TNF promoter 863A were independent risk markers for HLP. CONCLUSIONS: This genetic study is the first one to address the association of HLP with the CFTR mutation/ variant/haplotype and TNF promoter polymorphism in a Chinese HTG population. The results suggest that the occurrence of HLP is multifactorial and polygenic. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 33 条
[1]   Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis [J].
Beranek, H ;
Teich, N ;
Witt, H ;
Schulz, HU ;
Mössner, J ;
Keim, V .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (11) :1223-1227
[2]   ACUTE PANCREATITIS WITH HYPERLIPEMIA - INCIDENCE OF LIPID ABNORMALITIES IN ACUTE PANCREATITIS [J].
CAMERON, JL ;
CAPUZZI, DM ;
ZUIDEMA, GD ;
MARGOLIS, S .
ANNALS OF SURGERY, 1973, 177 (04) :483-489
[3]   Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis [J].
Chandak, GR ;
Idris, MM ;
Reddy, DN ;
Mani, KR ;
Bhaskar, S ;
Rao, GV ;
Singh, L .
GUT, 2004, 53 (05) :723-728
[4]  
Chang MC, 2003, HEPATO-GASTROENTEROL, V50, P1655
[5]   Spectrum of mutations and variants/haplotypes of CFTR and genotype-phenotype correlation in idiopathic chronic pancreatitis and controls in Chinese by complete analysis [J].
Chang, Ming-Chu ;
Chang, Yu-Ting ;
Wei, Shu-Chen ;
Tien, Yu-Wen ;
Liang, Po-Chin ;
Jan, I-Shiow ;
Su, Yi-Ning ;
Wong, Jau-Min .
CLINICAL GENETICS, 2007, 71 (06) :530-539
[6]   Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis [J].
Cohn, JA ;
Friedman, KJ ;
Noone, PG ;
Knowles, MR ;
Silverman, LM ;
Jowell, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (10) :653-658
[7]   Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes - The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation [J].
Cuppens, H ;
Lin, W ;
Jaspers, M ;
Costes, B ;
Teng, H ;
Vankeerberghen, A ;
Jorissen, M ;
Droogmans, G ;
Reynaert, I ;
Goossens, M ;
Nilius, B ;
Cassiman, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :487-496
[8]   A proinflammatory, antiapoptotic phenotype underlies the susceptibility to acute pancreatitis in cystic fibrosis transmembrane regulator (-/-) mice [J].
DiMagno, MJ ;
Lee, SH ;
Hao, YB ;
Zhou, SY ;
McKenna, BJ ;
Owyang, C .
GASTROENTEROLOGY, 2005, 129 (02) :665-681
[9]  
DOMINGUEZMUNOZ JE, 1991, INT J PANCREATOL, V10, P261
[10]   Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis [J].
Durno, C ;
Corey, M ;
Zielenski, J ;
Tullis, E ;
Tsui, LC ;
Durie, P .
GASTROENTEROLOGY, 2002, 123 (06) :1857-1864